查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942818

2026年全球血管内血管支架市场报告

Endovascular Stent Grafts Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，血管内血管支架市场呈指数级增长，预计将从2025年的14.5亿美元增长到2026年的19.9亿美元，复合年增长率达37.9%。成长要素包括对传统开放性手术的依赖、先进血管支架物材料的供不应求、血管疾病患病率的上升、冠状动脉和外周血管移植物早期应用以及人们对主动脉瘤治疗认识的提高。

预计未来几年，血管内血管支架市场将快速成长，到2030年市场规模将达到71.3亿美元，复合年增长率（CAGR）为37.5%。预测期内的成长要素包括血管内血管支架物技术的创新、微创手术的兴起、主动脉瘤和主动脉夹层病例的增加、混合血管移植物应用的日益普及以及心血管基础设施的不断完善。预测期内的主要趋势包括微创血管内治疗方法的日益普及、对定制血管支架需求的增长、混合和生物材料移植物技术的进步、胸主动脉和腹主动脉修復手术的扩展以及对患者安全和监管合规性的日益重视。

心血管疾病盛行率的不断上升正在推动血管内血管支架市场的未来扩张。心血管疾病是指影响心臟和血管的一系列疾病。心血管疾病盛行率的上升受生活型态、先前基础疾病、遗传易感性和环境因素的影响。血管内血管支架可以加强脆弱的血管壁，降低破裂风险，并提供有效的治疗方案，在最大限度减少侵入性手术干预的同时改善患者预后。例如，根据澳洲政府机构—澳洲健康与福利研究所 (AIHW) 的数据，截至 2025 年 10 月，预计到 2023 年，约有 57,100 名 25 岁及以上的成年人将患上急性冠状动脉症候群，平均每天约有 156 例。因此，心血管疾病盛行率的不断上升正在增强血管内血管支架市场的需求。

血管内血管支架市场的主要企业正致力于开发创新产品，例如胸主动脉血管支架，以提高治疗精准度、改善患者预后并应对复杂的解剖结构挑战。胸主动脉血管支架是一种专门用于透过血管内手术治疗胸主动脉疾病的医疗设备，提供了一种安全有效的微创治疗方案。例如，2024年2月，中国医疗设备製造商恩多斯泰克（Endovastec）推出了多分支胸主动脉血管支架系统（Hector），并在瑞士完成了首次临床应用。此系统的多分支设计能够在治疗复杂胸主动脉疾病的同时，维持关键动脉分支的血流。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球血管内血管支架市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 工业4.0和智慧製造
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 自主系统、机器人与智慧运输
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 微创血管内治疗方法的普及应用日益广泛
    • 对客製化血管支架的需求不断增长
    • 混合和生物接枝材料的进展
    • 扩大胸腹主动脉修补手术
    • 更加重视病人安全和监管合规性

第五章 终端用户产业市场分析

  • 循环系统专科医院
  • 综合医院
  • 专科手术中心
  • 医疗设备製造商
  • 研究和学术机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球血管内血管支架市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球血管内血管支架市场规模、比较及成长率分析
  • 全球血管内血管支架市场表现：规模与成长，2020-2025年
  • 全球血管内血管支架市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 血液透析通路移植、血管内血管支架、冠状动脉绕道手术移植、主动脉疾病血管移植、週边血管移植
  • 按原料
  • 合成血管移植物、生物血管移植物、混合血管移植物
  • 透过使用
  • 心臟动脉瘤、肾衰竭、血管阻塞、冠状动脉疾病
  • 按类型细分：血液透析通路移植
  • 动静脉瘻管移植片、合成血液透析通路移植片、生物工程血液透析通路移植片、涂层血液透析移植片、血管内血液透析移植片
  • 按类型细分：血管内血管支架
  • 用于动脉瘤的血管支架、主动脉夹层的血管支架、胸腔血管内血管支架、腹腔血管内支架血管支架、胆道血管内血管支架
  • 按类型细分：冠状动脉绕道手术手术
  • 大隐静脉移植（SVG）、动脉冠状动脉绕道手术手术、血管内冠状动脉绕道手术手术（CABG）、人工冠状动脉绕道手术手术
  • 按类型细分：主动脉疾病血管移植
  • 血管内主动脉血管支架、主动脉瘤移植物、主动脉绕道移植、胸腹主动脉血管支架、主动脉血管支架
  • 按类型细分：週边血管移植
  • 颈动脉血管支架、股动脉血管支架、腘动脉血管支架、髂动脉血管支架、週边血管内血管支架

第十章 区域与国家分析

  • 全球血管内血管支架市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球血管内血管支架市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 血管内血管支架市场：竞争格局与市场份额，2024 年
  • 血管内血管支架市场：公司估值矩阵
  • 血管内血管支架市场：公司概况
    • Abbott Laboratories
    • Medtronic PLC
    • Boston Scientific Corporation
    • Terumo Corporation
    • Cook Group Incorporated

第37章：其他领先和创新企业

  • Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, WL Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc.（MID）, Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年血管内血管支架市场：提供新机会的国家
  • 2030年血管内血管支架市场：充满新机会的细分市场
  • 2030年血管内血管支架市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MESGT01_G26Q1

Endovascular stent grafts are medical devices used to treat blood vessel problems such as aneurysms or narrowing. They consist of a metal mesh tube covered with a fabric graft and are inserted into the affected vessel through a catheter, usually via a large artery in the groin or arm. These devices repair damaged or weakened vessels and offer a less invasive alternative to open surgery.

The main product categories of endovascular stent grafts include hemodialysis access grafts, endovascular stent grafts, coronary artery bypass grafts, vascular grafts for aortic disease, and peripheral vascular grafts. Hemodialysis access grafts are specialized vascular grafts designed to create access for hemodialysis in patients with renal failure. The raw materials include synthetic vascular grafts, biological vascular grafts, and hybrid vascular grafts, which are used in applications such as cardiac aneurysms, kidney failure, vascular occlusions, and coronary artery diseases.

Tariffs are impacting the endovascular stent graft market by increasing costs of imported stent materials, including metal alloys and biologic graft fabrics. Segments like thoracic and abdominal endovascular stent grafts are most impacted, particularly in Asia-Pacific regions such as China and India, which are major production and import hubs. The resulting higher costs and potential supply chain delays have prompted manufacturers to explore local sourcing and production. Positively, tariffs have encouraged investment in domestic manufacturing capabilities and innovation in cost-efficient stent graft solutions.

The endovascular stent grafts market research report is one of a series of new reports from The Business Research Company that provides endovascular stent grafts market statistics, including endovascular stent grafts industry global market size, regional shares, competitors with a endovascular stent grafts market share, detailed endovascular stent grafts market segments, market trends and opportunities, and any further data you may need to thrive in the endovascular stent grafts industry. This endovascular stent grafts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endovascular stent grafts market size has grown exponentially in recent years. It will grow from $1.45 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 37.9%. The growth in the historic period can be attributed to reliance on conventional open surgical procedures, limited availability of advanced stent graft materials, growing prevalence of vascular diseases, early adoption of coronary and peripheral grafts, increasing awareness of aortic aneurysm treatments.

The endovascular stent grafts market size is expected to see exponential growth in the next few years. It will grow to $7.13 billion in 2030 at a compound annual growth rate (CAGR) of 37.5%. The growth in the forecast period can be attributed to technological innovations in endovascular stent grafts, rising minimally invasive surgeries, growth in aortic aneurysm and dissection cases, increasing adoption of hybrid vascular grafts, expansion of cardiovascular healthcare infrastructure. Major trends in the forecast period include increasing adoption of minimally invasive endovascular procedures, rising demand for customized stent grafts, advancements in hybrid and biologic graft materials, expansion of thoracic and abdominal aortic repair procedures, enhanced focus on patient safety and regulatory compliance.

The increasing prevalence of cardiovascular diseases is increasingly supporting the expansion of the endovascular stent graft market going forward. Cardiovascular disease refers to a broad category of conditions involving the heart or blood vessels. The rising prevalence of cardiovascular diseases is influenced by lifestyle behaviors, pre-existing medical conditions, genetic predispositions, and environmental factors. Endovascular stent grafts provide an effective treatment option by reinforcing weakened blood vessel walls, reducing rupture risk, and minimizing invasive surgical intervention while improving patient outcomes. For example, in October 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, an estimated 57,100 adults aged 25 years and older experienced acute coronary events in 2023, averaging approximately 156 cases per day. As a result, the growing prevalence of cardiovascular diseases is strengthening demand within the endovascular stent graft market.

Leading companies operating in the endovascular stent grafts market are focused on developing innovative products such as thoracic aortic stent grafts to improve treatment precision, enhance patient outcomes, and address complex anatomical challenges. A thoracic aortic stent graft is a specialized device used in endovascular surgery to manage diseases of the thoracic aorta by providing a safe and effective minimally invasive treatment option. For example, in February 2024, Endovastec, a China-based medical device company, introduced the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and completed its first clinical application in Switzerland. The system's multi-branch design allows treatment of complex thoracic aortic conditions while preserving blood flow to critical arterial branches.

In December 2023, TekniPlex Healthcare Inc., a US-based provider of medical device components, acquired Seisa Medical S.A. de C.V. for an undisclosed amount. Through this acquisition, TekniPlex aims to expand its medical device manufacturing capabilities and strengthen its presence in the Latin American healthcare market. Seisa Medical S.A. de C.V. is a Mexico-based manufacturer specializing in endovascular stent grafts.

Major companies operating in the endovascular stent grafts market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc., Alvimedica, Endospan Ltd., Vivasure Medical Ltd.

North America was the largest region in the endovascular stent grafts market in 2025. The regions covered in the endovascular stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endovascular stent grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The endovascular stent grafts market consists of sales of aortoiliac stent grafts, thoracic endograft, and abdominal endografts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endovascular Stent Grafts Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses endovascular stent grafts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endovascular stent grafts ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endovascular stent grafts market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Hemodialysis Access Grafts; Endovascular Stent Grafts; Coronary Artery By-Pass Grafts; Vascular Grafts For Aorta Disease; Peripheral Vascular Grafts
  • 2) By Raw Material: Synthetic Vascular Grafts; Biological Vascular Grafts; Hybrid Vascular Grafts
  • 3) By Application: Cardiac Aneurysm; Kidney Failure; Vascular Occlusion; Coronary Artery Disease
  • Subsegments:
  • 1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts; Synthetic Hemodialysis Access Grafts; Bioengineered Hemodialysis Access Grafts; Coated Hemodialysis Grafts; Endovascular Hemodialysis Grafts
  • 2) By Endovascular Stent Grafts: Aneurysm Stent Grafts; Stent Grafts For Aortic Dissection; Thoracic Endovascular Stent Grafts; Abdominal Endovascular Stent Grafts; Biliary Endovascular Stent Grafts
  • 3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG); Arterial Coronary Bypass Grafts; Endovascular Coronary Artery Bypass Grafts (CABG); Synthetic Coronary Bypass Grafts
  • 4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts; Aortic Aneurysm Grafts; Aortic Bypass Grafts; Thoracoabdominal Aortic Stent Grafts; Aortic Dissection Stent Grafts
  • 5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts; Femoral Artery Stent Grafts; Popliteal Artery Stent Grafts; Iliac Artery Stent Grafts; Peripheral Endovascular Stent Grafts
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Terumo Corporation; Cook Group Incorporated; Merit Medical Systems Inc.; Biotronik SE & Co KG; MicroPort Scientific Corporation; Endologix LLC; LeMaitre Vascular Inc.; Lifetech Scientific Corporation; W. L. Gore & Associates Inc.; Braile Biomedica; BrosMed Medical BV; Micro Interventional Devices Inc. (MID); Lombard Medical Inc.; Endovastec Medical Technology Co Ltd.; Jotec GmbH; Bentley InnoMed GmbH; Bolton Medical Inc.; Alvimedica; Endospan Ltd.; Vivasure Medical Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Endovascular Stent Grafts Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Endovascular Stent Grafts Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Endovascular Stent Grafts Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Endovascular Stent Grafts Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Industry 4.0 & Intelligent Manufacturing
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Autonomous Systems, Robotics & Smart Mobility
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Minimally Invasive Endovascular Procedures
    • 4.2.2 Rising Demand For Customized Stent Grafts
    • 4.2.3 Advancements In Hybrid And Biologic Graft Materials
    • 4.2.4 Expansion Of Thoracic And Abdominal Aortic Repair Procedures
    • 4.2.5 Enhanced Focus On Patient Safety And Regulatory Compliance

5. Endovascular Stent Grafts Market Analysis Of End Use Industries

  • 5.1 Cardiovascular Hospitals
  • 5.2 General Hospitals
  • 5.3 Specialized Surgical Centers
  • 5.4 Medical Device Manufacturers
  • 5.5 Research And Academic Institutions

6. Endovascular Stent Grafts Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Endovascular Stent Grafts Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Endovascular Stent Grafts PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Endovascular Stent Grafts Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Endovascular Stent Grafts Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Endovascular Stent Grafts Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Endovascular Stent Grafts Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Endovascular Stent Grafts Market Segmentation

  • 9.1. Global Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts For Aorta Disease, Peripheral Vascular Grafts
  • 9.2. Global Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts
  • 9.3. Global Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease
  • 9.4. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Hemodialysis Access Grafts, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts
  • 9.5. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Endovascular Stent Grafts, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts
  • 9.6. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Coronary Artery By-Pass Grafts, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts
  • 9.7. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Vascular Grafts For Aorta Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts
  • 9.8. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Peripheral Vascular Grafts, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts

10. Endovascular Stent Grafts Market Regional And Country Analysis

  • 10.1. Global Endovascular Stent Grafts Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Endovascular Stent Grafts Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Endovascular Stent Grafts Market

  • 11.1. Asia-Pacific Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Endovascular Stent Grafts Market

  • 12.1. China Endovascular Stent Grafts Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Endovascular Stent Grafts Market

  • 13.1. India Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Endovascular Stent Grafts Market

  • 14.1. Japan Endovascular Stent Grafts Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Endovascular Stent Grafts Market

  • 15.1. Australia Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Endovascular Stent Grafts Market

  • 16.1. Indonesia Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Endovascular Stent Grafts Market

  • 17.1. South Korea Endovascular Stent Grafts Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Endovascular Stent Grafts Market

  • 18.1. Taiwan Endovascular Stent Grafts Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Endovascular Stent Grafts Market

  • 19.1. South East Asia Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Endovascular Stent Grafts Market

  • 20.1. Western Europe Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Endovascular Stent Grafts Market

  • 21.1. UK Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Endovascular Stent Grafts Market

  • 22.1. Germany Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Endovascular Stent Grafts Market

  • 23.1. France Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Endovascular Stent Grafts Market

  • 24.1. Italy Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Endovascular Stent Grafts Market

  • 25.1. Spain Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Endovascular Stent Grafts Market

  • 26.1. Eastern Europe Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Endovascular Stent Grafts Market

  • 27.1. Russia Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Endovascular Stent Grafts Market

  • 28.1. North America Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Endovascular Stent Grafts Market

  • 29.1. USA Endovascular Stent Grafts Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Endovascular Stent Grafts Market

  • 30.1. Canada Endovascular Stent Grafts Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Endovascular Stent Grafts Market

  • 31.1. South America Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Endovascular Stent Grafts Market

  • 32.1. Brazil Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Endovascular Stent Grafts Market

  • 33.1. Middle East Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Endovascular Stent Grafts Market

  • 34.1. Africa Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Endovascular Stent Grafts Market Regulatory and Investment Landscape

36. Endovascular Stent Grafts Market Competitive Landscape And Company Profiles

  • 36.1. Endovascular Stent Grafts Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Endovascular Stent Grafts Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Endovascular Stent Grafts Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Cook Group Incorporated Overview, Products and Services, Strategy and Financial Analysis

37. Endovascular Stent Grafts Market Other Major And Innovative Companies

  • Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc.

38. Global Endovascular Stent Grafts Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Endovascular Stent Grafts Market

40. Endovascular Stent Grafts Market High Potential Countries, Segments and Strategies

  • 40.1 Endovascular Stent Grafts Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Endovascular Stent Grafts Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Endovascular Stent Grafts Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer